Developers claim 95% efficacy for Russian Sputnik V COVID vaccine

About This Source - RT

The video item below is a piece of English language content from RT (formerly Russia Today). RT is a Russian state-funded broadcaster.

Recent from RT:

  • Huge blast rocks Madrid, at least 6 reportedly injured
  • ‘The movement we started is only just beginning’, Trump says in farewell speech
  • Washington DC ahead of US Presidential inauguration
  • RT published this video item, entitled “Developers claim 95% efficacy for Russian Sputnik V COVID vaccine” – below is their description.

    The team behind Russia’s Sputnik V COVID vaccine, Moscow’s Gamaleya Center, has claimed that its jab is 95% effective, proving to be even more efficient than previously thought. To discuss the news, RT talks to Ian Jones, a virology professor at the University of Reading.

    RT YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • President Donald Trump Lauds His ‘Incredible Four Years’ in Farewell Speech
  • Gordon Brown Slams the Government for Locking Down Too Little, Too Late and Too Lax | GMB
  • Ask Dr H: Why Does the UK Have the Worst Death Rate? | Good Morning Britain
  • Italian restaurants refuse to close doors despite COVID restrictions
  • PMQ’s: Boris Johnson questioned over timing of Covid border measures and loss of police records
  • In This Story: Sputnik V

    Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.

    The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.

    On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.

    2 Recent Items: Sputnik V

  • Serbian health minister receives China’s Sinopharm vaccine
  • Kenyan healthcare workers go on strike – vaccine shortage in Africa | Coronavirus Update
  • Leave a Comment